Key players in the global radiodermatitis market are engaged in reimbursment scenarios, research & development, technological advancements, launch of new products, and acquisition & collaborative agreements with other companies. These strategies of key players are likely to fuel the growth of the global radiodermatitis market. A few expansion strategies adopted by players operating in the global radiodermatitis market are:
The report on the global Radiodermatitis Market discussed individual strategies, followed by company profiles of manufacturers of drugs for managing Radiodermatitis condition. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global Radiodermatitis Market.
Global Radiodermatitis Market - Segmentation
Product |
|
Distribution Channel |
|
Region |
|
The global radiodermatitis market was worth US$ 334.2 Mn and is projected to reach a value of US$ 506.3 Mn by the end of 2027
Radiodermatitis market is anticipated to grow at a CAGR of 3.3% during the forecast period
Asia Pacific accounted for a major share of the global radiodermatitis market
Radiodermatitis market is driven by rise in cancer cases and lifestyle factors contributing to cancer leading to radiodermatitis and Rise in adverse events during radiation with chemotherapy to drive market
Key players in the global radiodermatitis market include 3M & Co., Acelity, BMG Pharma S.r.l., ConvaTec, DermaSciences Inc., Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew plc, Stratpharma AG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Radiodermatitis Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Radiodermatitis Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Value Chain Analysis
5. Key Insights
5.1. Disease Provenance across Region/Globally
5.2. Pipeline Analysis
6. Global Radiodermatitis Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Radiodermatitis Market Value Forecast, by Product , 2017–2027
6.2.1. Topical
6.2.1.1. Corticosteroids
6.2.1.2. Hydrophilic Creams
6.2.1.3. Topical Antibiotics
6.2.2. Oral Medication
6.2.2.1. Corticosteroids
6.2.2.2. Oral analgesics & Antibiotics
6.2.3. Dressings
6.2.3.1. Hydrogel
6.2.3.2. Hydrocolloid
6.2.3.3. No sting Barrier film
6.2.3.4. Honey Impregnated gauze
6.2.3.5. Silicone coated dressing
6.2.3.6. Others
6.3. Global Radiodermatitis Market Attractiveness, by Product
7. Global Radiodermatitis Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Radiodermatitis Market Value Forecast, by Distribution Channel , 2017–2027
7.2.1. Hospital Pharmacy
7.2.2. Retail Pharmacy Store
7.2.3. Online Store
7.3. Global Radiodermatitis Market Attractiveness, by Distribution Channel
8. Global Radiodermatitis Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Radiodermatitis Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Radiodermatitis Market Attractiveness, by Region
9. North America Radiodermatitis Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Radiodermatitis Market Value (US$ Mn) Forecast, by Product , 2017–2027
9.2.1. Topical
9.2.1.1. Corticosteroids
9.2.1.2. Hydrophilic Creams
9.2.1.3. Topical Antibiotics
9.2.2. Oral Medication
9.2.2.1. Corticosteroids
9.2.2.2. Oral analgesics & Antibiotics
9.2.3. Dressings
9.2.3.1. Hydrogel
9.2.3.2. Hydrocolloid
9.2.3.3. No sting Barrier film
9.2.3.4. Honey Impregnated gauze
9.2.3.5. Silicone coated dressing
9.2.3.6. Others
9.3. North America Radiodermatitis Market Value (US$ Mn) Forecast, by Distribution Channel , 2017–2027
9.3.1. Hospital Pharmacy
9.3.2. Retail Pharmacy Store
9.3.3. Online Store
9.4. North America Radiodermatitis Market Value (US$ Mn) Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Radiodermatitis Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Distribution Channel
9.5.3. By Country
10. Europe Radiodermatitis Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Radiodermatitis Market Value (US$ Mn) Forecast, by Product , 2017–2027
10.2.1. Topical
10.2.1.1. Corticosteroids
10.2.1.2. Hydrophilic Creams
10.2.1.3. Topical Antibiotics
10.2.2. Oral Medication
10.2.2.1. Corticosteroids
10.2.2.2. Oral analgesics & Antibiotics
10.2.3. Dressings
10.2.3.1. Hydrogel
10.2.3.2. Hydrocolloid
10.2.3.3. No sting Barrier film
10.2.3.4. Honey Impregnated gauze
10.2.3.5. Silicone coated dressing
10.2.3.6. Others
10.3. Europe Radiodermatitis Market Value (US$ Mn) Forecast, by Distribution Channel , 2017–2027
10.3.1. Hospital Pharmacy
10.3.2. Retail Pharmacy Store
10.3.3. Online Store
10.4. Europe Radiodermatitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Radiodermatitis Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-region
11. Asia Pacific Radiodermatitis Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Radiodermatitis Market Value (US$ Mn) Forecast, by Product , 2017–2027
11.2.1. Topical
11.2.1.1. Corticosteroids
11.2.1.2. Hydrophilic Creams
11.2.1.3. Topical Antibiotics
11.2.2. Oral Medication
11.2.2.1. Corticosteroids
11.2.2.2. Oral analgesics & Antibiotics
11.2.3. Dressings
11.2.3.1. Hydrogel
11.2.3.2. Hydrocolloid
11.2.3.3. No sting Barrier film
11.2.3.4. Honey Impregnated gauze
11.2.3.5. Silicone coated dressing
11.2.3.6. Others
11.3. Asia Pacific Radiodermatitis Market Value (US$ Mn) Forecast, by Distribution Channel , 2017–2027
11.3.1. Hospital Pharmacy
11.3.2. Retail Pharmacy Store
11.3.3. Online Store
11.4. Asia Pacific Radiodermatitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Radiodermatitis Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-region
12. Latin America Radiodermatitis Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Radiodermatitis Market Value (US$ Mn) Forecast, by Product , 2017–2027
12.2.1. Topical
12.2.1.1. Corticosteroids
12.2.1.2. Hydrophilic Creams
12.2.1.3. Topical Antibiotics
12.2.2. Oral Medication
12.2.2.1. Corticosteroids
12.2.2.2. Oral analgesics & Antibiotics
12.2.3. Dressings
12.2.3.1. Hydrogel
12.2.3.2. Hydrocolloid
12.2.3.3. No sting Barrier film
12.2.3.4. Honey Impregnated gauze
12.2.3.5. Silicone coated dressing
12.2.3.6. Others
12.3. Latin America Radiodermatitis Market Value (US$ Mn) Forecast, by Distribution Channel , 2017–2027
12.3.1. Hospital Pharmacy
12.3.2. Retail Pharmacy Store
12.3.3. Online Store
12.4. Latin America Radiodermatitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Radiodermatitis Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Distribution Channel s
12.5.3. By Country/Sub-region
13. Middle East & Africa Radiodermatitis Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Radiodermatitis Market Value (US$ Mn) Forecast, by Product , 2017–2027
13.2.1. Topical
13.2.1.1. Corticosteroids
13.2.1.2. Hydrophilic Creams
13.2.1.3. Topical Antibiotics
13.2.2. Oral Medication
13.2.2.1. Corticosteroids
13.2.2.2. Oral analgesics & Antibiotics
13.2.3. Dressings
13.2.3.1. Hydrogel
13.2.3.2. Hydrocolloid
13.2.3.3. No sting Barrier film
13.2.3.4. Honey Impregnated gauze
13.2.3.5. Silicone coated dressing
13.2.3.6. Others
13.3. Middle East & Africa Radiodermatitis Market Value (US$ Mn) Forecast, by Distribution Channel , 2017–2027
13.3.1. Hospital Pharmacy
13.3.2. Retail Pharmacy Store
13.3.3. Online Store
13.4. Middle East & Africa Radiodermatitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Radiodermatitis Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Distribution Channel
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Share Analysis
14.2. Company Profiles
14.2.1. 3M
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Financial Overview
14.2.1.3. Growth Strategies
14.2.1.4. SWOT Analysis
14.2.2. BMG Pharma
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Growth Strategies
14.2.2.3. SWOT Analysis
14.2.3. ConvaTec Inc
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Financial Overview
14.2.3.3. Growth Strategies
14.2.3.4. SWOT Analysis
14.2.4. Integra Life Sciences
14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2. Financial Overview
14.2.4.3. Growth Strategies
14.2.4.4. SWOT Analysis
14.2.5. Intermed Pharmaceuticals
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Financial Overview
14.2.5.3. Growth Strategies
14.2.5.4. SWOT Analysis
14.2.6. Molnlycke Health Care AB
14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.6.2. Financial Overview
14.2.6.3. Growth Strategies
14.2.6.4. SWOT Analysis
14.2.7. Smith & Nephew
14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.7.2. Financial Overview
14.2.7.3. Growth Strategies
14.2.7.4. SWOT Analysis
14.2.8. Stratpharma AG
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Growth Strategies
14.2.8.3. SWOT Analysis
List of Tables
Table 01: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 03: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 04: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 05: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 06: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 07: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 08: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 09: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 11: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel , 2017–2027
Table 12: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 14: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 15: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 17: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 18: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
List of Figures
Figure 01 : Global Radiodermatitis Market Snapshot
Figure 02: Global Radiodermatitis Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 03: Global Radiodermatitis Market Value (US$ Mn) Forecast, 2017?2027
Figure 04: Global Radiodermatitis Market Value Share, by Product , 2018
Figure 05: Global Radiodermatitis Market Value Share, by Distribution Channel 2018
Figure 06: Global Radiodermatitis Market Value Share, by Region, 2018
Figure 07: Global Radiodermatitis Market Value Share Analysis, by Product , 2018 and 2027
Figure 08: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2017–2027
Figure 11: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017–2027
Figure 12: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hydrophilic Creams, 2017–2027
Figure 13: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical Antibiotics, 2017–2027
Figure 14: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral Medication, 2017–2027
Figure 15: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017–2027
Figure 16: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral analgesics & Antibiotics, 2017–2027
Figure 17: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Dressings, 2017–2027
Figure 18: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hydrogel, 2017–2027
Figure 19: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hydrocolloid, 2017–2027
Figure 20: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by No sting Barrier film, 2017–2027
Figure 21: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Honey Impregnated gauze, 2017–2027
Figure 22: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Silicone coated dressing, 2017–2027
Figure 23: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027
Figure 24: Global Radiodermatitis Market Attractiveness Analysis , by Product , 2019–2027
Figure 25: Global Radiodermatitis Market Value Share Analysis, by Distribution Channel 2018 and 2027
Figure 26: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacy , 2017–2027
Figure 27: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacy Store , 2017–2027
Figure 28: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Store , 2017–2027
Figure 29: Global Radiodermatitis Market Attractiveness Analysis , by Distribution Channel 2019–2027
Figure 30: Global Radiodermatitis Market Snapshot, by Country/Sub-region
Figure 31: Global Radiodermatitis Market Value Share Analysis, by Region 2018 and 2027
Figure 32: Global Radiodermatitis Market Attractiveness Analysis , by Region, 2019–2027
Figure 33: North America Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 34: North America Radiodermatitis Market Value Share (%), by Product , 2018 and 2027
Figure 35: North America Radiodermatitis Market Attractiveness Analysis , by Product , 2019–2027
Figure 36: North America Radiodermatitis Market Value Share (%), by Distribution Channel 2018 and 2027
Figure 37: North America Radiodermatitis Market Attractiveness Analysis , by Distribution Channel 2019–2027
Figure 38: North America Radiodermatitis Market Value Share (%), by Country/ Sub-region, 2018 and 2027
Figure 39: North America Radiodermatitis Market Attractiveness Analysis , by Country/ Sub-region, 2019–2027
Figure 40: Europe Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 41: Europe Radiodermatitis Market Value Share (%), by Product , 2018 and 2027
Figure 42: Europe Radiodermatitis Market Attractiveness Analysis , by Product , 2019–2027
Figure 43: Europe Radiodermatitis Market Value Share (%), by Distribution Channel 2018 and 2027
Figure 44: Europe Radiodermatitis Market Attractiveness Analysis , by Distribution Channel 2019–2027
Figure 45: Europe Radiodermatitis Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 46: Europe Radiodermatitis Market Attractiveness Analysis , by Country/Sub-region, 2019–2027
Figure 47: Asia Pacific Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 48: Asia Pacific Radiodermatitis Market Value Share (%), by Product , 2018 and 2027
Figure 49: Asia Pacific Radiodermatitis Market Attractiveness Analysis , by Product , 2019–2027
Figure 50: Asia Pacific Radiodermatitis Market Value Share (%), by Distribution Channel 2018 and 2027
Figure 51: Asia Pacific Radiodermatitis Market Attractiveness Analysis , by Distribution Channel 2019–2027
Figure 52: Asia Pacific Radiodermatitis Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 53: Asia Pacific Radiodermatitis Market Attractiveness Analysis , by Country/Sub-region, 2019–2027
Figure 54: Latin America Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 55: Latin America Radiodermatitis Market Value Share (%), by Product , 2018 and 2027
Figure 56: Latin America Radiodermatitis Market Attractiveness Analysis , by Product , 2019–2027
Figure 57: Latin America Radiodermatitis Market Value Share (%), by Distribution Channel 2018 and 2027
Figure 58: Latin America Radiodermatitis Market Attractiveness Analysis , by Distribution Channel 2019–2027
Figure 59: Latin America Radiodermatitis Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 60: Latin America Radiodermatitis Market Attractiveness Analysis , by Country/Sub-region, 2019–2027
Figure 61: Middle East & Africa Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 62 : Middle East & Africa Radiodermatitis Market Value Share (%), by Product , 2018 and 2027
Figure 63: Middle East & Africa Radiodermatitis Market Attractiveness Analysis , by Product , 2019–2027
Figure 64 : Middle East & Africa Radiodermatitis Market Value Share (%), by Distribution Channel 2018 and 2027
Figure 65: Middle East & Africa Radiodermatitis Market Attractiveness Analysis , by Distribution Channel 2019–2027
Figure 66: Middle East & Africa Radiodermatitis Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 67: Middle East & Africa Radiodermatitis Market Attractiveness Analysis , by Country/Sub-region, 2019–2027